SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORP 2070.SE :

* BOARD APPROVES CAPITAL INCREASE OF DAMMAM PHARMACEUTICAL TO 180 MILLION RIYALS FROM 120 MILLION RIYALS

* CO WILL CONTRIBUTE ITS SHARE OF 39 MILLION RIYALS IN CAPITAL INCREASE

Source text for Eikon: ID:nSSE8NYPQn Further company coverage: 2070.SE

((Reuters.Briefs@thomsonreuters.com;))